Oh, look! A story in the WSJ about all the new mon

Oh, look! A story in the WSJ about all the new mono-clonal antibody treatments that may help in the fight against Covid. Wait, there seems to be one missing. Is it the one that is furthest along in clinical trials? Yeah, that's it - the one that showed the best efficacy with the best safety profile among all the candidates. How did our kiss-up to BP overlook that one, what was it again? Oh, yeah, leronlimab was its' name, made by some tiny little company in Canada, was it? Vancouver, right? Oh, that's here in the US? How the heck did the WSJ overlook CytoDyn AGAIN? Don't expect to hear it tonight when Professor Windb ag grabs the mike at 6pm to announce the remarkable new development in treating that "chinese virus" he's been blubbering about. Here's half the breaking news I was referring to: https://www.msn.com/en-us/health/medical/anti...li=BBnb7Kz